Skip to main content

Table 1 Incidence of bloodstream infection (BSI) stratified by sex in an area of Mid-Norway 2002-2013. Number of episodes and observed and standardized incidence rates, allover and in various subgroups, are shown

From: Burden of bloodstream infection in an area of Mid-Norway 2002-2013: a prospective population-based observational study

 

Total

Females

Males

Group of BSI

n

Observed BSI

ratea

(95% C.I.)

Age and sex standar- dized rateb

n

Observed BSI

ratea

(95% CI)

Age standar-dized rate c

n

Observed BSI ratea

(95% CI)

Age standar-dizedrate d

All BSIs

1995

232 (222–242)

215

961

221 (208–236)

209

1034

242 (228–258)

222

Agee

 16–64 years

578

84 (78–92)

82

284

84 (75–94)

83

294

84 (75–95)

82

 65–79 years

692

564 (523–607)

555

306

477 (425–534)

473

386

658 (594–727)

646

 ≥80 years

725

1379 (1280–1483)

1373

371

1122 (1011–1242)

1126

354

1813 (1629–2012)

1826

Place of acquisition

 CA-BSI

934

109 (102–116)

102

502

116 (106–126)

110

432

101 (92–111)

94

 HCA-BSI

787

91 (85–98)

85

356

82 (74–91)

78

431

101 (92–111)

91

 HA-BSI

274

32 (28–36)

30

103

24 (19–29)

23

171

40 (34–47)

37

Infection focus

 Urinary tract

752

87 (81–94)

81

429

99 (90–109)

94

323

76 (68–84)

68

 Lungs

331

38 (34–43)

36

142

33 (28–39)

31

189

44 (38–51)

41

 Biliary tract

220

26 (22–29)

24

93

21 (17–26)

21

127

30 (25–35)

27

 Gastrointestinal tract

101

12 (10–14)

11

44

10 (7–14)

9.8

57

13 (10–17)

13

 Skin or soft tissue

143

17 (14–20)

16

61

14 (11–18)

13

82

19 (15–24)

18

 Other

247

29 (25–33)

27

104

24 (20–29)

23

143

34 (28–39)

31

 Unknown

201

23 (20–27)

22

88

20 (16–25)

19

113

26 (22–32)

24

Microbe group

 Gram-negative BSI

1133

132 (124–140)

123

616

142 (131–154)

135

517

121 (111–132)

110

 Gram-positive BSI

777

90 (84 to 97)

85

310

71 (64–80)

68

467

109 (100–120)

101

 Polymicrobial or fungal BSI

85

10 (8–12)

9

35

8 (6–11)

8

50

12 (8–15)

11

Microbes (the four most common)

Escherichia coli

686

80 (74–86)

74

421

97 (88–107)

93

265

62 (55–70)

56

Streptococcus pneumoniae

226

26 (23–30)

25

109

25 (21–30)

24

117

27 (23–33)

25

Staphylococcus aureus

218

25 (22–29)

24

75

17 (14–22)

16

143

34 (28–39)

31

Klebsiella spp.

134

16 (13–18)

14

65

15 (12–19)

14

69

16 (13–20)

15

  1. aBSI episodes per 100,000 person-years (totally 860,630 person-years in individuals ≥16 years, 426, 517 in males, 434,113 in females)
  2. bmales and females standardized to the age distribution of the male and female population of Norway 2010, respectively
  3. cstandardized to the age distribution of females in Norway 2010
  4. dstandardized to the age distribution of males in Norway 2010
  5. ePerson-years in the three age groups were: 16–64 years: males 348,342; females 336,950; 65–79 years: males 58,645; females 64,100; ≥80 years: males 19,530; females 33,063